N-acetylmuramoyl-L-alanine amidase is a biomarker for remission of type 2 diabetes after bariatric surgery

Authors :: Anthony Wetton
Rachelle Donn
Bethany Geary
Helene A Fachim
Adrian Heald
Alan Campbell
Akheel A. Syed
J. M. Gibson
Handrean Soran
Zohaib Iqbal
Ivona Baricevic-Jones
Source :: Endocrine Abstracts.
Publication Year :: 2021
Publisher :: Bioscientifica, 2021.

Subjects :: medicine.medical_specialty
business.industry
Internal medicine
Biomarker (medicine)
Medicine
Type 2 diabetes
business
medicine.disease
N-acetylmuramoyl-L-alanine amidase
Gastroenterology

Full Text Access

Tools